pharmaceuticals

Egyptian health tech Yodawy raises $16M, backed by Delivery Hero Ventures

Without proper government-led public health initiatives, healthcare expenditures, including insurance and pharmaceutical drugs, can burden individuals and households. In recent years, private institut

Quantori is building an app development platform focused on life sciences

Life science businesses like big pharmaceutical companies have a singular set of needs when it comes to building applications. Their models and algorithms tend to be more sophisticated and data-intens

Extortion group claims cyberattack on pharmaceutical giant IPCA Laboratories

IPCA Laboratories, one of the biggest pharmaceutical companies in India, has been hit by a cybercrime and extortion group that claims to have stolen 500 gigabytes of data from its systems. Nandakishor

Mermade Seafoods swims in cell agriculture waters to make cultivated scallops

Mermade Seafoods' circular approach uses biowaste to feed algae, which is then used as the growth media to feed the cells. The company calls this interpretation of aquaponics “cytoponics."

Facebook and Instagram are removing posts offering to mail abortion pills

In the aftermath of the Supreme Court’s decision to overturn Roe v. Wade, some Facebook and Instagram users planning to help distribute legal abortion pills are finding themselves censored. Acco

Despite regulatory hurdles, these 4 US cannabis investors are planting seeds for tomorrow

Bear markets and high interest rates often cause investors to turn away from anything resembling a risky investment. Yet, now is a good time to take another look at the cannabis sector in the U.S.

6 questions investors should ask when evaluating psychedelic biotech companies

We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.

Vira Health gets $12M to dial up personalized menopause support

Vira Health, a U.K. startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus

Fullscript raises $240M to expand its B2B integrative medicine marketplace

The market for complementary and alternative medicine — a wide-ranging area that includes practice-based work like yoga as well as a huge range of supplements and everything in between — h

NFX-backed Pepper Bio Emerges from stealth with tools to hone in on complex diseases

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have re

The next healthcare revolution will have AI at its center

Human life expectancy increased from 31 years in 1900 to 72 years in 2017. Today, we are on the cusp of another healthcare revolution driven by artificial intelligence.

AgBiome lands $116M for safer crop protection technology

The company captures diverse microbes for agricultural applications, like crop protection, and screens strains for the best assays that would work for insect, disease and nematode control.

Aduhelm approval sparks HHS watchdog review of FDA’s accelerated approval pathway

The Department of Health and Human Services (HHS) Office of the Inspector General will review the FDA’s accelerated approval pathway, the office announced Wednesday. This sweeping review comes just

Powered by local stores, JOKR joins the 15-min grocery race with a $170M Series A

“We are true believers in the fact that the world needs a new Amazon, a better one, a more sustainable one, one that appreciates local areas and products.” It’s quite one thing to claim you are

Ukrainian police arrest multiple Clop ransomware gang suspects

Multiple suspects believed to be linked to the Clop ransomware gang have been detained in Ukraine after a joint operation from law enforcement agencies in Ukraine, South Korea and the United States. T

After contentious debate, FDA approves first Alzheimer’s drug since 2003

On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by the drugmaker Biogen. The decision to approve the drug, which was once

Wolt closes $530M round to continue expanding beyond restaurant delivery

Wolt, the Helsinki-based online ordering and delivery company that initially focused on restaurants but has since expanded to other verticals, has raised $530 million in new funding. The round was led

Men’s health subscription startup Numan closes £10M Series A funding round

Launched almost 18 months ago, Numan joined the growing list of sites targeting men’s health, such as Roman and Hims, for example. Numan launched aiming to promote accessible medical remedies for er

Digital elective care and telemedicine provider Ro raises $200 million at a reported $1.5 billion valuation

In three years Zachariah Reitano’s startup, Ro, has managed to hit a reported $1.5 billion valuation for its transformation from a company focused on treating erectile dysfunction to a telemedic

VC’s largest funds make big bets on vertical B2B marketplaces

During the waning days of the first dot-com boom, some of the biggest names in venture capital invested in marketplaces and directories whose sole function was to consolidate information and foster tr
Load More